Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

In patients with Alzheimer's disease, amyloid fibrils that are aggregates of A4 protein subunits are deposited in the brain. A similar process occurs at an earlier age in persons with Down's syndrome. To investigate the deposition of amyloid in these diseases, we used a radioimmunoassay to measure levels of the amyloid precursor (PreA4) in the serum of 17 patients with Down's syndrome, 15 patients with Alzheimer's disease, and 33 normal elderly controls. The mean (+/- SD) concentration of serum PreA4 was increased 1.5-fold in patients with Down's syndrome (2.49 +/- 1.13 nmol per liter) as compared with that in controls (1.68 +/- 0.49 nmol per liter; P less than 0.007); the levels in patients with Alzheimer's disease were similar to those in controls (1.83 +/- 0.78; P less than 0.98). We also found that the concentration of PreA4 in the brain tissue of two adults with Down's syndrome (100 and 190 pmol per gram) was higher than that in the brain tissue of either 26 patients with Alzheimer's disease (64.4 +/- 17.3 pmol per gram) or 17 elderly controls with neurologic disease (68.5 +/- 26.3 pmol per gram). Immunocytochemical studies of brain tissue from 26 patients with Down's syndrome showed that the deposition of A4 protein amyloid began in these patients approximately 50 years earlier than it began in 127 normal aging subjects studied previously, although the rate of deposition was the same. We conclude that, since the gene for PreA4 is on the long arm of chromosome 21, which is present in triplicate in Down's syndrome, overexpression of this gene may lead to increased levels of PreA4 and amyloid deposition in Down's syndrome. However, since increased levels of PreA4 are not present in Alzheimer's disease, additional factors must account for the amyloid deposition in that disorder.

[1]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[2]  S. Vermund,et al.  Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. , 1988, American journal of obstetrics and gynecology.

[3]  R. Martins,et al.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease , 1988, Neurology.

[4]  G. Multhaup,et al.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. , 1988, The EMBO journal.

[5]  G. Multhaup,et al.  Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. , 1988, The EMBO journal.

[6]  J. Morrison,et al.  Distribution of precursor amyloid-beta-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Shiojiri,et al.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.

[8]  L. Villa-komaroff,et al.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease , 1988, Nature.

[9]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[10]  C. Masters,et al.  Localization of the putative precursor of Alzheimer's disease‐specific amyloid at nuclear envelopes of adult human muscle. , 1988, The EMBO journal.

[11]  S. Younkin,et al.  In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Morrison,et al.  Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Mirra,et al.  Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly Racemized , 1988, Journal of neurochemistry.

[14]  C. Finch,et al.  Transferrin receptors in rat plasma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Villa,et al.  Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. , 1988, The Journal of general virology.

[16]  William I. Wood,et al.  Growth hormone receptor and serum binding protein: purification, cloning and expression , 1987, Nature.

[17]  S. Prusiner,et al.  Distinct prion proteins in short and long scrapie incubation period mice , 1987, Cell.

[18]  S. Latt,et al.  The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. , 1987, Science.

[19]  D. Selkoe,et al.  Gene dosage of the amyloid beta precursor protein in Alzheimer's disease. , 1987, Science.

[20]  D. Pollen,et al.  Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. , 1987, Science.

[21]  J. Haines,et al.  The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene , 1987, Nature.

[22]  C. Broeckhoven,et al.  Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families , 1987, Nature.

[23]  S. Prusiner,et al.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[24]  J. Morrison,et al.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. , 1987, Science.

[25]  T. Becker,et al.  Genital human papillomavirus infection. A growing concern. , 1987, Obstetrics and gynecology clinics of North America.

[26]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Vinters,et al.  High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. , 1987, Biochemical and biophysical research communications.

[28]  J. Delabar,et al.  Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome , 1987, Science.

[29]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[30]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[31]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[32]  N. Robakis,et al.  CHROMOSOME 21q21 SUBLOCALISATION OF GENE ENCODING BETA-AMYLOID PEPTIDE IN CEREBRAL VESSELS AND NEURITIC (SENILE) PLAQUES OF PEOPLE WITH ALZHEIMER DISEASE AND DOWN SYNDROME , 1987, The Lancet.

[33]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[34]  J. Delabar,et al.  The beta amyloid protein (AD-AP) cDNA hybridizes in normal and Alzheimer individuals near the interface of 21q21 and q22.1. , 1987, Annales de genetique.

[35]  S. Prusiner,et al.  Linkage of prion protein and scrapie incubation time genes , 1986, Cell.

[36]  C. Epstein.  The Neurobiology of Down syndrome , 1986 .

[37]  S. Prusiner,et al.  Scrapie prion proteins are synthesized in neurons. , 1986, The American journal of pathology.

[38]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[39]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.

[40]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[42]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[43]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[44]  S. Prusiner,et al.  Scrapie PrP 27-30 is a sialoglycoprotein , 1985, Journal of virology.

[45]  J. Kent,et al.  Parathyroid hormone radioimmunoassay: the clinical evaluation of assays using commercially available reagents. , 1985, Journal of immunoassay.

[46]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[47]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[48]  I. Lott.  Down's Syndrome, Aging, and Alzheimer's Disease: A Clinical Review * , 1982, Annals of the New York Academy of Sciences.

[49]  C. Masters,et al.  The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. , 1981, Brain : a journal of neurology.

[50]  Burger Hg,et al.  A generalized computer program for the treatment of data from competitive protein-binding assays including radioimmunoassays. , 1972 .

[51]  J. Thorell,et al.  Enzymatic iodination of polypeptides with 125I to high specific activity. , 1971, Biochimica et biophysica acta.